43 results
Page 2 of 3
8-K
k7g6sxzn jh23b5kc
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
8-K
2kuv0 fr84a2e2
6 Apr 20
Departure of Directors or Certain Officers
8:30am
424B5
eta4rhz2ij6550xk
9 Jan 20
Prospectus supplement for primary offering
5:25pm
424B5
41upcsykpa6g
7 Jan 20
Prospectus supplement for primary offering
4:19pm
424B5
yg619x0gudqwywf mq
7 Mar 19
Prospectus supplement for primary offering
4:28pm
424B5
p1wuilae5s0 nwnka7x
6 Mar 19
Prospectus supplement for primary offering
4:07pm